(en) Thompson AGB, Luk C, Heslegrave AJ, Zetterburg H, Jackson GS et al., « Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression », J Neurol Neurosurg Psychiatry, vol. 89, no 9, , p. 955-61. (PMID29487167, PMCIDPMC6109239, DOI10.1136/jnnp-2017-317793, lire en ligne [html])
(en) Takada LT, Kim M-O, Cleveland RW, Wong K, Geschwind MD et al., « Genetic prion disease: experience of a rapidly progressive dementia center in the United States and a review of the literature », Am J Med Genet B Neuropsychiatr Genet, vol. 174, no 1, , p. 36-69. (PMID27943639, PMCIDPMC7207989, DOI10.1002/ajmg.b.32505, lire en ligne [html])
Jean-Philippe Brandel, M. Bustuchina Vlaicu, Audrey Culeux et Maxime Belondrade, « Variant Creutzfeldt–Jakob Disease Diagnosed 7.5 Years after Occupational Exposure », New England Journal of Medicine, vol. 383, no 1, , p. 83–85 (ISSN0028-4793, DOI10.1056/NEJMc2000687, lire en ligne, consulté le )
(en) Thompson AGB, Luk C, Heslegrave AJ, Zetterburg H, Jackson GS et al., « Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression », J Neurol Neurosurg Psychiatry, vol. 89, no 9, , p. 955-61. (PMID29487167, PMCIDPMC6109239, DOI10.1136/jnnp-2017-317793, lire en ligne [html])
(en) Thompson AGB, Anastasiadis P, Druyeh R, Whitworth I, Mead S et al., « Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases », Mol Psychiatry, vol. 26, no 10, , p. 5955-66. (PMID33674752, PMCIDPMC8758487, DOI10.1038/s41380-021-01045-w, lire en ligne [html])
(en) Llorens F, Villar-Piqué A, Schmitz M, Diaz-Lucena D, Zerr I et al., « Plasma total prion protein as a potential biomarker for neurodegenerative dementia: diagnostic accuracy in the spectrum of prion diseases », Neuropathol Appl Neurobiol, vol. 46, no 3, , p. 240-54. (PMID31216593, DOI10.1111/nan.12573, lire en ligne [html])
(en) Cazzaniga FA, Bistaffa E, De Luca CMG, Bufano G, Moda F et al., « Sporadic Creutzfeldt-Jakob disease: real-time quaking induced conversion (RT-QuIC) assay represents a major diagnostic advance », Eur J Histochem, vol. 65, no s1, , p. 3298-3298. (PMID34657408, PMCIDPMC8529530, DOI10.4081/ejh.2021.3298, lire en ligne)
(en) Karapetyan YE, Sferrazza GF, Zhou M, Ottenberg G, Spicer T, Chase P, Fallahi M, Hodder P, Weissmann C, Lasmézas CI., « Unique drug screening approach for prion diseases identifies tacrolimus and astemizole as antiprion agents », Proc Natl Acad Sci U S A., vol. 110, no 17, , p. 7044-9. (PMID23576755, DOI10.1073/pnas.1303510110).
doi.org
Jean-Philippe Brandel, M. Bustuchina Vlaicu, Audrey Culeux et Maxime Belondrade, « Variant Creutzfeldt–Jakob Disease Diagnosed 7.5 Years after Occupational Exposure », New England Journal of Medicine, vol. 383, no 1, , p. 83–85 (ISSN0028-4793, DOI10.1056/NEJMc2000687, lire en ligne, consulté le )
Jean-Philippe Brandel, M. Bustuchina Vlaicu, Audrey Culeux et Maxime Belondrade, « Variant Creutzfeldt–Jakob Disease Diagnosed 7.5 Years after Occupational Exposure », New England Journal of Medicine, vol. 383, no 1, , p. 83–85 (ISSN0028-4793, DOI10.1056/NEJMc2000687, lire en ligne, consulté le )
« Recherche sur les prions : un rapport d’inspection dénonce des conditions de sécurité insuffisantes », La Croix, (ISSN0242-6056, lire en ligne, consulté le )
« Recherche sur les prions : un rapport d’inspection dénonce des conditions de sécurité insuffisantes », La Croix, (ISSN0242-6056, lire en ligne, consulté le )
(en) Thompson AGB, Anastasiadis P, Druyeh R, Whitworth I, Mead S et al., « Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases », Mol Psychiatry, vol. 26, no 10, , p. 5955-66. (PMID33674752, PMCIDPMC8758487, DOI10.1038/s41380-021-01045-w, lire en ligne [html])
(en) Takada LT, Kim M-O, Cleveland RW, Wong K, Geschwind MD et al., « Genetic prion disease: experience of a rapidly progressive dementia center in the United States and a review of the literature », Am J Med Genet B Neuropsychiatr Genet, vol. 174, no 1, , p. 36-69. (PMID27943639, PMCIDPMC7207989, DOI10.1002/ajmg.b.32505, lire en ligne [html])
(en) Thompson AGB, Luk C, Heslegrave AJ, Zetterburg H, Jackson GS et al., « Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression », J Neurol Neurosurg Psychiatry, vol. 89, no 9, , p. 955-61. (PMID29487167, PMCIDPMC6109239, DOI10.1136/jnnp-2017-317793, lire en ligne [html])
(en) Thompson AGB, Anastasiadis P, Druyeh R, Whitworth I, Mead S et al., « Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases », Mol Psychiatry, vol. 26, no 10, , p. 5955-66. (PMID33674752, PMCIDPMC8758487, DOI10.1038/s41380-021-01045-w, lire en ligne [html])
(en) Llorens F, Villar-Piqué A, Schmitz M, Diaz-Lucena D, Zerr I et al., « Plasma total prion protein as a potential biomarker for neurodegenerative dementia: diagnostic accuracy in the spectrum of prion diseases », Neuropathol Appl Neurobiol, vol. 46, no 3, , p. 240-54. (PMID31216593, DOI10.1111/nan.12573, lire en ligne [html])
(en) Cazzaniga FA, Bistaffa E, De Luca CMG, Bufano G, Moda F et al., « Sporadic Creutzfeldt-Jakob disease: real-time quaking induced conversion (RT-QuIC) assay represents a major diagnostic advance », Eur J Histochem, vol. 65, no s1, , p. 3298-3298. (PMID34657408, PMCIDPMC8529530, DOI10.4081/ejh.2021.3298, lire en ligne)
(en) Karapetyan YE, Sferrazza GF, Zhou M, Ottenberg G, Spicer T, Chase P, Fallahi M, Hodder P, Weissmann C, Lasmézas CI., « Unique drug screening approach for prion diseases identifies tacrolimus and astemizole as antiprion agents », Proc Natl Acad Sci U S A., vol. 110, no 17, , p. 7044-9. (PMID23576755, DOI10.1073/pnas.1303510110).
(en) Takada LT, Kim M-O, Cleveland RW, Wong K, Geschwind MD et al., « Genetic prion disease: experience of a rapidly progressive dementia center in the United States and a review of the literature », Am J Med Genet B Neuropsychiatr Genet, vol. 174, no 1, , p. 36-69. (PMID27943639, PMCIDPMC7207989, DOI10.1002/ajmg.b.32505, lire en ligne [html])
(en) Llorens F, Villar-Piqué A, Schmitz M, Diaz-Lucena D, Zerr I et al., « Plasma total prion protein as a potential biomarker for neurodegenerative dementia: diagnostic accuracy in the spectrum of prion diseases », Neuropathol Appl Neurobiol, vol. 46, no 3, , p. 240-54. (PMID31216593, DOI10.1111/nan.12573, lire en ligne [html])
